Matsushita R, Sakurai A, Minamitani K, Yamazaki M, Uchino S.
Extra-endocrine phenotypes at infancy in multiple endocrine neoplasia type 2B: A case series of six Japanese patients.
Clin Pediatr Endocrinol. 30(4): 195-200, 2021.
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
J Gastroenterol. 56(11): 1033-1044, 2021.
Shimura H, Matsumoto Y, Murakami T, Fukunari N, Kitaoka M, Suzuki S.
Diagnostic strategies for thyroid nodules based on ultrasonographic findings in Japan.
Cancers. 13(18): 4629, 2021. https://doi.org/10.3390/cancers13184629.
Shah R, Sehemby M, Garg R, Purandare N, Hira P, Mahajan A, Lele V, Malhotra G, Verma P, Rojekar A, Dalvi A, Uchino S, Rastogi S, Lila A, Patil V, Shah N, Bandgar T.
68 Ga-DOTATATE PET/CT imaging in endogenous hyperinsulinemic hypoglycemia: A tertiary endocrine centre experience.
Clin Endocrinol (Oxf). 96(2): 190-199, 2022.
Shah R, Gosavi V, Mahajan A, Sonawane S, Hira P, Kurki V, Bal M, Sathe P, Pai P, D’Cruz A, Uchino S, Garale MN, Patil V, Lila A, Shah N, Bandgar T.
Preoperative prediction of parathyroid carcinoma in an Asian Indian cohort.
Head Neck. 43(7): 2069-2080, 2021.
Nakakura S, Hosomichi K, Uchino S, Murakami A, Oka A, Inoue I, Nakaoka H.
HLA-B*39:01:01 is a novel risk factor for antithyroid drug-induced agranulocytosis in Japanese population.
Pharmacogenomics J. 21(1): 94-101, 2021.